Novartis AG (NVS)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account

Sell

$152.50

Buy

$160.74

arrow-down$-1.09 (-0.71%)

Prices updated at 14 Apr 2026, 21:54 EDT

Prices minimum 15 mins delay

Prices in USD

Novartis AG is a part of the healthcare industry. Its main activity is to research and develop healthcare products and pharmaceuticals such as oncology medicines, generic and biosimilar medicines and eye care devices.

S&P 500

1.18%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2024	2025
	51,722m	56,674m
	38,895m	42,975m
	14,544m	17,644m
	28.12	31.13
	11,941m	13,984m
	20,715m	22,821m
Sales, General and administrative	12,566m	13,248m
Interest expenses	1,006m	1,144m
Provision for income taxes	1,701m	2,385m
Operating expenses	24,351m	25,331m
Income before taxes	13,640m	16,352m
Net income available to common shareholders	11,941m	13,984m
	5.92	7.21
Net interest income	-686m	-980m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	5.87	7.15
Free cash flow per share	6.0965	8.6473
Book value/share	21.9317	23.2319
Debt equity ratio	0.520683	0.641491

Balance sheet

Year chevron-l-regular chevron-r-regular	2024	2025
Current assets	29,704m	30,460m
Current liabilities	28,692m	27,278m
Total capital	65,412m	74,065m
Total debt	31,258m	35,376m
Total equity	44,046m	46,130m
Total non current liabilities	-	-
Loans	21,366m	27,935m
Total assets	102,246m	110,949m
Total liabilities	-	-
Cash and cash equivalents	11,459m	11,435m
Common stock	1,975m	1,908m

Cash flow

Year chevron-l-regular chevron-r-regular	2024	2025
Cash at beginning of period	13,393m	11,459m
Cash dividends paid	-7,624m	-7,818m
	13,805m	15,244m
Investments (gains) losses	-7,513m	-4,877m
	11,459m	11,435m
Net income	-	-
	17,619m	19,144m
	-3,814m	-3,900m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.